• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小鼠骨髓中“null”淋巴细胞和Thy1lo淋巴细胞的群体动力学:具有自然杀伤细胞谱系特征的细胞起源

Population dynamics of "null" and Thy1lo lymphocytes in mouse bone marrow: genesis of cells with natural killer cell lineage characteristics.

作者信息

Rahal M D, Koo G C, Osmond D G

机构信息

Department of Anatomy, McGill University, Montreal, Quebec, Canada.

出版信息

Cell Immunol. 1991 Apr 15;134(1):111-25. doi: 10.1016/0008-8749(91)90335-9.

DOI:10.1016/0008-8749(91)90335-9
PMID:1672834
Abstract

The population dynamics of "null" small lymphocytes lacking B and T lineage markers in mouse bone marrow have been examined using a combination of immunolabeling and hydroxyurea (HU) deletion techniques. The binding of the B lineage-associated mAb, 14.8, and anti-Thy1.2 to bone marrow cells has been detected radioautographically. Null cells lacking 14.8 and Thy1.2 determinants (14.8- Thy1-) formed a substantial subset (12-14%) of bone marrow small lymphocytes, representing 0.5 x 10(6) cells per femur (2-3% of nucleated cells). HU treatment revealed an exceptionally rapid turnover of the null small lymphocyte population (T1/2, 7.5 hr) compared with 14.8+ cells (T1/2, 20.5 hr) and Thy1+ cells (T1/2, 53 hr). Small lymphocytes bearing low intensities of Thy1 (Thy1lo) were also rapidly renewed (T1/2, 28 hr) whereas those with high intensities of Thy1 (Thy1hi) were renewed only slowly (T1/2, 123 hr). During ontogeny, null small lymphocytes first appeared in the fetal liver by Day 11 and the fetal spleen by Day 16, but increased rapidly in the bone marrow in early postnatal life. Double immunolabeling techniques demonstrated that 10% of null small lymphocytes in the bone marrow expressed NK1.1 antigen, while larger proportions bound to tumor (YAC.1) cells in vitro and displayed Fc receptors. The NK1.1-bearing fraction of null small lymphocytes in bone marrow was depleted by HU treatment only after an initial delay. NK1.1 was also expressed on subsets of Thy1lo cells and Thy1hi cells. The results have revealed the continuous production in mouse bone marrow of null and Thy1lo small lymphocytes, totaling 1-3 x 10(7) cells/day and 1.2 x 10(6) cells/day, respectively. The findings suggest that the large-scale production of null lymphocytes in mouse bone marrow includes the genesis of NK lineage cells which express NK1.1 and Thy1lo during a period of terminal maturation.

摘要

运用免疫标记和羟基脲(HU)缺失技术相结合的方法,对小鼠骨髓中缺乏B和T谱系标记的“无标记”小淋巴细胞的群体动力学进行了研究。通过放射自显影检测B谱系相关单克隆抗体14.8和抗Thy1.2与骨髓细胞的结合。缺乏14.8和Thy1.2决定簇(14.8 - Thy1-)的无标记细胞构成了骨髓小淋巴细胞的一个重要亚群(12 - 14%),每根股骨中有0.5×10⁶个细胞(占核细胞的2 - 3%)。与14.8⁺细胞(半衰期为20.5小时)和Thy1⁺细胞(半衰期为53小时)相比,HU处理显示无标记小淋巴细胞群体的更新速度异常快(半衰期为7.5小时)。低强度表达Thy1(Thy1lo)的小淋巴细胞更新也很快(半衰期为28小时),而高强度表达Thy1(Thy1hi)的小淋巴细胞更新则很慢(半衰期为123小时)。在个体发育过程中,无标记小淋巴细胞在第11天首次出现在胎肝中,在第16天出现在胎脾中,但在出生后早期骨髓中迅速增加。双重免疫标记技术表明,骨髓中10%的无标记小淋巴细胞表达NK1.1抗原,而更大比例的细胞在体外与肿瘤(YAC.1)细胞结合并显示Fc受体。骨髓中无标记小淋巴细胞的NK1.1阳性部分在HU处理后仅在初始延迟后才减少。NK1.1也在Thy1lo细胞和Thy1hi细胞亚群上表达。结果表明,小鼠骨髓中持续产生无标记和Thy1lo小淋巴细胞,分别总计为每天1 - 3×10⁷个细胞和每天1.2×10⁶个细胞。这些发现表明,小鼠骨髓中无标记淋巴细胞的大规模产生包括NK谱系细胞的生成,这些细胞在终末成熟阶段表达NK1.1和Thy1lo。

相似文献

1
Population dynamics of "null" and Thy1lo lymphocytes in mouse bone marrow: genesis of cells with natural killer cell lineage characteristics.小鼠骨髓中“null”淋巴细胞和Thy1lo淋巴细胞的群体动力学:具有自然杀伤细胞谱系特征的细胞起源
Cell Immunol. 1991 Apr 15;134(1):111-25. doi: 10.1016/0008-8749(91)90335-9.
2
Changes in the populations of null, NK1.1+, and Thy1lo lymphocytes in the bone marrow of tumor-bearing mice: effect of indomethacin treatment.荷瘤小鼠骨髓中零细胞、NK1.1⁺细胞和Thy1lo淋巴细胞群体的变化:吲哚美辛治疗的影响
Cell Immunol. 1992 Jan;139(1):218-28. doi: 10.1016/0008-8749(92)90114-5.
3
Altered production and renewal of natural killer cells in B-lymphocyte-deficient CBA/N mice.B淋巴细胞缺陷的CBA/N小鼠中自然杀伤细胞的产生和更新改变。
Nat Immun Cell Growth Regul. 1989;8(5):245-54.
4
Maturation of bone marrow lymphocytes. II. Development of Fc and complement receptors and surface immunoglobulin studied by rosetting and radioautography.骨髓淋巴细胞的成熟。II. 通过玫瑰花结形成试验和放射自显影术研究Fc和补体受体以及表面免疫球蛋白的发育
J Exp Med. 1978 Nov 1;148(5):1251-70. doi: 10.1084/jem.148.5.1251.
5
Maturation of bone marrow lymphocytes. IV. Kinetics of maturation and renewal of lymphocytes expressing Ia and H-2K antigens.骨髓淋巴细胞的成熟。IV. 表达Ia和H-2K抗原的淋巴细胞的成熟和更新动力学。
Immunology. 1981 Nov;44(3):463-72.
6
The cytolytic activity of natural killer cells is not involved in the restriction of Mycobacterium avium growth.自然杀伤细胞的细胞溶解活性不参与限制鸟分枝杆菌的生长。
Int Immunol. 2003 Aug;15(8):895-901. doi: 10.1093/intimm/dxg089.
7
The in vivo role of murine natural killer cells in the development of B cell lineage in bone marrow.
Tokai J Exp Clin Med. 1985 Dec;10(6):621-9.
8
Both gamma delta T cells and NK cells inhibit the engraftment of xenogeneic rat bone marrow cells and the induction of xenograft tolerance in mice.γδT细胞和自然杀伤细胞均能抑制异种大鼠骨髓细胞的植入以及小鼠异种移植耐受性的诱导。
J Immunol. 2001 Jan 15;166(2):1398-404. doi: 10.4049/jimmunol.166.2.1398.
9
Suppression of B-cell differentiation by natural killer (asialo GM1+) cells in mice.小鼠中自然杀伤(去唾液酸GM1+)细胞对B细胞分化的抑制作用。
Nat Immun Cell Growth Regul. 1986;5(2):75-89.
10
A subfraction of B220(+) cells in murine bone marrow and spleen does not belong to the B cell lineage but has dendritic cell characteristics.小鼠骨髓和脾脏中B220(+)细胞的一个亚群不属于B细胞谱系,而是具有树突状细胞特征。
Eur J Immunol. 2002 Mar;32(3):686-92. doi: 10.1002/1521-4141(200203)32:3<686::AID-IMMU686>3.0.CO;2-I.

引用本文的文献

1
Posttranscriptional regulation of II10 gene expression allows natural killer cells to express immunoregulatory function.IL-10基因表达的转录后调控使自然杀伤细胞能够发挥免疫调节功能。
Immunity. 2008 Aug 15;29(2):295-305. doi: 10.1016/j.immuni.2008.06.012.
2
Similar rates of production of T and B lymphocytes in the bone marrow.骨髓中T淋巴细胞和B淋巴细胞的产生速率相似。
J Exp Med. 1995 Jun 1;181(6):2201-11. doi: 10.1084/jem.181.6.2201.